Rapid progress in the field of biotechnology has introduced a myriad of pressing ethical issues associated with stem cell research. Worldwide and particularly in Asian countries, where stem cell therapy is more advanced, the ethical basis of utilizing stem cell therapy as a treatment modality is based on the Declaration of Helsinki (DoH) on the ethical principles for medical research involving human subjects. This Declaration of Helsinki is a set of ethical principles regarding human experimentation developed for the medical fraternity and is drafted by the World Medical Association (WMA). It is widely regarded as the cornerstone document on the bioethics of human research.
The following is an excerpt from the Declaration of Helsinki:
“In the treatment of an individual patient, where proven interventions do not exist or other known interventions have been ineffective, the physician, after seeking expert advice, with informed consent from the patient or a legally authorised representative, may use an unproven intervention if in the physician’s judgement it offers hope of saving life, reestablishing health or alleviating suffering. This intervention should subsequently be made the object of research, designed to evaluate its safety and efficacy. In all cases, new information must be recorded and, where appropriate, made publicly available.”
Hence, as per the Declaration of Helsinki, stem cell therapy can be utilized for conditions which have no other treatments available. At MedicoNegotiator, we strictly adhere to and abide by the above stated Declaration.
GlobalSpace Healthcare Technologies PVT LTD
303-304, Building No. 5, Sector 3
Millennium Business Park, Mahape,
Navi Mumbai, Maharashtra,
India-400710.
Copyright Notice
©2022 MedicoNegotiator All Rights Reserved